(lp0
S"Amicus Therapeutics, Inc. : From Top to Bottom StockNewsJournal - 14 hours ago Amicus Therapeutics, Inc.  is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $6.82, down from yesterday's close by -6.19%.Amicus Therapeutics Inc.  Plunges 6.13% on March 21 - Equities.comZacks Investment Research Upgrades Amicus Therapeutics, Inc.  to Hold - Petro Global News 24"
p1
aS"Why Amicus Therapeutics, Inc. Jumped Higher Today Motley Fool - Mar 1, 2017 Amicus Therapeutics  ended the day up 17%, after the company's CEO John Crowley and his daughter Megan  were highlighted during President Donald Trump's address to Congress last night.The Unlikely Story Of How Amicus Therapeutics Came To Be - BenzingaAmicus Therapeutics, Inc.  Could Be The Force That Brings Change ... - Market Exclusive"
p2
aS"How Does the Chart Look for Amicus Therapeutics, Inc.  ? The USA Commerce - 14 hours ago We have gathered the technical data on Amicus Therapeutics, Inc. , and see some interesting trends in the stock's behavior of late."
p3
aS'Eye on Technicals for Amicus Therapeutics Inc  Baxter Review - 12 hours ago When applying indicators for technical analysis, traders and investors might want to examine the ATR or Average True Range. The current 14-day ATR for Amicus Therapeutics Inc  is currently sitting at 0.38. The ATR basically measures the ...'
p4
aS'Amicus Therapeutics Inc.  Soars 7.89% on February 27 Equities.com - Feb 27, 2017 Amicus Therapeutics Inc.  had a good day on the market for Monday February 27 as shares jumped 7.89% to close at $6.43.'
p5
aS'Amicus Therapeutics Launches Galafold  for Treatment of Fabry ... GlobeNewswire  - Feb 27, 2017 CRANBURY, N.J., Feb. 27, 2017  -- Amicus Therapeutics , a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision medicine Galafold in the&nbsp;...Amicus Therapeutics  Launches Galafold in the UK - StreetInsider.com'
p6
aS'The Charts For Amicus Therapeutics, Inc.  Is Attracting Massive Attention NY Stock News - Mar 21, 2017 The technicals for Amicus Therapeutics, Inc.  have taken shape, and with them a comprehensive picture has emerged.'
p7
aS'Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate ... GlobeNewswire  - Mar 1, 2017 CRANBURY, N.J., March 01, 2017  -- Amicus Therapeutics , a biotechnology company at the forefront of therapies for rare and orphan diseases, today announced financial results for the full year ended December 31,&nbsp;...Amicus Therapeutics, Inc.  Receives Prestigious SOTU Attention - StockNewsUnion'
p8
aS'Buy, Sell or Hold? Analysts Approach: Amicus Therapeutics, Inc. , Coeur ... The USA Commerce - Mar 21, 2017 Amicus Therapeutics, Inc.  share price increased in the last trading session with a previous 52-week high of $9.83.'
p9
aS"Today's Research Reports on Biotech Stocks to Watch: Amicus Therapeutics and ... Yahoo Finance - Mar 17, 2017 Amicus has had a number of investment firms, including JP Morgan Chase, confirming or raising their rating of the company from a &quot;hold&quot; to a &quot;buy&quot; during the early months of 2017, with consensus rating as &quot;outperform&quot;. The company specializes in the&nbsp;..."
p10
a.